Danish Diabetes and Endocrine Academy Allocates Multi-million Grant to Early-career Research Talent and Visiting Professors

Posted on 14.06.2023

Obesity, diabetes, cardiovascular and hormone-related diseases are closely related and growing in number of affected individuals worldwide. This is reflected in the 13 million Danish kroner research grant allocation from the Danish Diabetes and Endocrine Academy (DDEA) to 13 Danish and international early-career researchers and three visiting professors.

Read more about the 16 grant recipients and their projects

The grant is, among other things, going to help early-career researchers better understand the mechanisms behind appetite-regulating hormones; the prevention of type 2 diabetes in young couples with a history of gestational diabetes; how to reduce cardiovascular complications to diabetes through dietary supplements and artificial intelligence; and which effect it has to use frozen/thawed eggs versus fresh eggs in fertility treatment for the child’s further development.

– The funded projects will establish strong collaborations across leading universities, research academies, hospitals and life science industry. They cover a wide field from basic research that may lead to future medicinal products to biomarkers that can predict the healing of diabetic foot ulcers, and to clinical research that will benefit the end user relatively fast, says Chairman of the DDEA Board of Directors, Allan Flyvbjerg.

Allan Flyvbjerg points out that the grant competition has been extremely high.

– The international grant review committee has judged all funded projects to be of the highest international quality. The chosen early-career researchers will make a significant difference for people with obesity, diabetes, cardiovascular and/or hormone-related diseases, their relatives and society, says Allan Flyvbjerg.

For the first time, the DDEA collaborates with the Danish Cardiovascular Academy (DCA) about three cross-academy scholarships. Allan Flyvbjerg and Director of DCA, Christian Aalkjær, are happy that the academies have the possibility to support the next generation of early-career researchers and clinicians within diabetes, hormone-related and cardiovascular diseases.

DDEA Grants

In total, the Danish Diabetes and Endocrine Academy (DDEA) has allocated 13,040,000 DKK. Read more about the 16 grant recipients.

Three scholarships are allocated in cooperation with the Danish Cardiovascular Academy and two with support from Novo Nordisk and Zealand Pharma.

The next call for applications will open 20 June 2023 with application deadline 23 August 2023.

The DDEA is funded by the Novo Nordisk Foundation 2022 – 2027.

Contact Information

Chairman of Board of Directors, Allan Flyvbjerg
Tel.: 0045 5177 9548
E-mail: allan.flyvbjerg1@outlook.dk

Managing Director, Tore Christiansen
Tel.: 0045 2964 6764
E-mail: tore.christiansen@rsyd.dk

Copyright © 2023 Danish Diabetes and Endocrine Academy. All Rights Reserved • Privacy Policy